Peplin skin cancer gel looks promising

Posted on Wednesday, May 03 2006 @ 9:10 CEST by Thomas De Maesschalck
Early clinical trials of a new gel from Peplin to treat skin cancer have returned promising results. The gel is based on a molecule from the raw sap of a petty spurge and it can be rubbed on to the skin to treat certain types of skin cancer.
Initial trials show just two applications of the PEP005 Topical gel on two consecutive days cleared up 71 per cent of basal cell carcinomas, or BCCs, the most common type of skin cancer.
More info over at The Age.

Loading Comments